MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with L

Letrozole

Letrozole 2.5mg tablets

Use with caution

Stability notes for Letrozole 2.5mg tablets

Store in airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Femara 2.5mg tablets (Novartis Pharmaceuticals UK Ltd).

Suppliers (16) of Letrozole 2.5mg tablets
Femara 2.5mg tablets (Abacus Medicine Ltd)
Femara 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
Letrozole 2.5mg tablets (A A H Pharmaceuticals Ltd)
Letrozole 2.5mg tablets (Accord-UK Ltd)
Letrozole 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Letrozole 2.5mg tablets (Amarox Ltd)
Letrozole 2.5mg tablets (Bristol Laboratories Ltd)
Letrozole 2.5mg tablets (Cipla EU Ltd)
Letrozole 2.5mg tablets (Crescent Pharma Ltd)
Letrozole 2.5mg tablets (Firstline Pharma Ltd)
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Letrozole 2.5mg tablets (Manx Healthcare Ltd)
Letrozole 2.5mg tablets (Medihealth (Northern) Ltd)
Letrozole 2.5mg tablets (Novumgen Ltd)
Letrozole 2.5mg tablets (Sigma Pharmaceuticals Plc)
Letrozole 2.5mg tablets (Torrent Pharma (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.